DI FILIPPO, Clara
 Distribuzione geografica
Continente #
EU - Europa 2.457
NA - Nord America 2.452
AS - Asia 260
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
OC - Oceania 2
Totale 5.179
Nazione #
US - Stati Uniti d'America 2.449
IE - Irlanda 790
UA - Ucraina 452
GB - Regno Unito 352
DE - Germania 235
SE - Svezia 177
CN - Cina 161
IT - Italia 149
FI - Finlandia 120
FR - Francia 87
TR - Turchia 71
GR - Grecia 59
BE - Belgio 15
VN - Vietnam 12
PL - Polonia 9
EU - Europa 6
ID - Indonesia 4
IN - India 4
CA - Canada 3
JP - Giappone 3
AT - Austria 2
AU - Australia 2
IR - Iran 2
NL - Olanda 2
PK - Pakistan 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
KR - Corea 1
PT - Portogallo 1
Totale 5.179
Città #
Dublin 790
Jacksonville 676
Chandler 530
Princeton 116
Ann Arbor 100
Medford 94
Boardman 87
Woodbridge 70
San Mateo 67
Bremen 63
Wilmington 61
Roxbury 50
Caserta 48
Beijing 42
Cambridge 28
Ashburn 26
Nanjing 25
Düsseldorf 24
Norwalk 22
Jinan 21
Napoli 17
Brussels 15
Aversa 14
Auburn Hills 13
New York 13
Des Moines 12
Dong Ket 12
Mountain View 11
Los Angeles 9
Nanchang 9
Shenyang 8
Hebei 7
Houston 7
Radomsko 7
Haikou 6
Lanzhou 6
Ningbo 6
Venice 6
Helsinki 5
Kunming 5
Milan 5
Casoria 4
Grumo Nevano 4
Hanover 4
Jakarta 4
Lappeenranta 4
London 4
Seattle 4
Casavatore 3
Hangzhou 3
Taizhou 3
Zhengzhou 3
Boscotrecase 2
Changsha 2
Fairfield 2
Fremont 2
Grafing 2
Groningen 2
Karachi 2
Kraków 2
Nocera Inferiore 2
Ottawa 2
Setagaya-ku 2
Tianjin 2
Washington 2
Andover 1
Atlanta 1
Berlin 1
Bushey 1
Changchun 1
Collegeville 1
Coral Gables 1
Dearborn 1
Florence 1
Giugliano In Campania 1
Guangzhou 1
Jiaxing 1
Lausanne 1
Leawood 1
Mcallen 1
Miami 1
Orange 1
Pistoia 1
Pozzuoli 1
Pune 1
Redmond 1
Redwood City 1
Renton 1
Sofia 1
Sorrento 1
Stockholm 1
Sydney 1
Syracuse 1
Taiyuan 1
Tokyo 1
Winnipeg 1
Yicheng 1
Zanjan 1
Totale 3.232
Nome #
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders 92
Beneficial Effect of Ursodeoxycholic Acid on High Glucose-Induced Long QT Interval Arrhythmia in Isolated Rat Heart 82
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 78
Chronic peripheral ouabain treatment affects the brain endothelin system of rats 76
Terapia del glaucoma: the cannabinoids way. 73
The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control 72
Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment 70
Daily Oxygen/O₃ Treatment Reduces Muscular Fatigue and Improves Cardiac Performance in Rats Subjected to Prolonged High Intensity Physical Exercise. 70
Intravitreal Injections of Melanocortin Receptor 1, 5 Agonists Prevents Neovascularization in a VEGF165 Mouse Model of Retinopathy 69
Inhibition of Ocular Aldose Reductase by a New Benzofuroxane Derivative Ameliorates Rat Endotoxic Uveitis 68
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 64
M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart. 62
MYOCARDIAL RECRUITMENT OF ENDOTHELIAL PROGENITOR CELLS FOLLOWING ADMINISTRATION OF OXYGEN/OZONE MIXTURE IN INFARCTED RAT HEART 62
Effects of 5-perfluorophenyl/octyl/butyl-substituted derivatives of aromatic/heterocyclic sulfonamides on carbonic anhydrase II activity in vitro and on betamethasone-induced ocular hypertension in rabbits 61
Ubiquitin-proteasome system as a progression factor of carotid plaques in diabetic patients: effects of rosiglitazone therapy 61
Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists 60
Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion 60
Hyperglycemia in streptozotocin-induced diabetes prolongs the inflammatory response of endotoxin-induced uveitis due to reduced ciliary body heme oxygenase-1 levels 60
Absence of inducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglycemic mice 58
Antiarrhythmic effect of acute oxygen-ozone administration to rats 58
Acute oxygen-ozone administration to rats protects the heart from ischemia reperfusion infarct 57
Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. 57
Arrhythmias induced by myocardial ischemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists 57
Acute myocardial infarct in Streptozotocin-induced hyperglycemic rats: protection from CORM-3 56
Protective role of melanocortin type 3 receptor in myocardial ischaemia-reperfusion injury in mice 56
Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3). 56
Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome. 56
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. 55
Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats 55
Local administration of ETA (but not ETB) blockers into the pag area of the brain decreases blood pressure of DOCA-salt rats 55
Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1 55
The cardio-protective properties of NCX-6550, a nitric oxide donating pravastatin, in the mouse 54
Effects of Irbesartan on the Growth and Differentiation of Adypocytes in Obese Zucker Rats 54
The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes 53
Thiazolidinediones may contribute to the intramyocardial lipid accumulation in diabetic myocardium: effects on cardiac function 52
Annexin 1 derived peptides protect against experimental myocardial ischemia-reperfusion injury 52
Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes 51
Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain 51
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. 51
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment 51
Ubiquitin-proteasome system contributes to the inflammatory injury of experimental acute diabetic myocardial infarct 51
Naloxone and naltrindole increase the nociceptive effect of cholecystokinin into the ventral periaqueductal gray area of rats 51
Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor 51
ETA endothelin receptors are involved in the ouabain-induced haemodynamic effects in the periaqueductal gray area of rats 50
Angiotensin II and the superior colliculus: role of AT2 receptors in cardiovascular events 50
Depressor responses to endothelin-1 in the superior colliculus involve ETB and adrenergic receptors 50
Zucher Diabetic Fatty rats with metabolic syndrome are protected from acute myocardial infarction by three weeks treatment with telmisartan 50
High levels of serum ubiquitin and proteasome in a case of HLA-B27 uveitis 50
Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women 48
Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque - Effects of rosiglitazone treatment 48
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN 48
Antiarrhytmic effect of acute oxygen-ozone administration to rats 48
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokine and PMN 47
Reperfusion-induced arrhythmias but not ischemia-induced arrhythmias are sensitive to ionotropic glutamate receptor antagonism 47
Effects of the new aldose reductase inhibitor benzofuroxane derivative bf-5m on high glucose induced prolongation of cardiac qt interval and increase of coronary perfusion pressure 47
Angiotensin II, via an action at AT1 receptors, may modulate the behavioural effects of ET-1 in conscious rats 46
AT1 receptors mediate pressor responses induced by angiotensin II in the periaqueductal gray area of rats 46
Intraperitoneal oxygen/ozone treatment decreases the formation of experimental postsurgical peritoneal adhesions and the levels/activity of the local ubiquitin-proteasome system. 46
The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: Role of glycemic control 45
INHIBITION OF ENDOGENOUS DIPEPTIDYL PEPTIDASE-4 IN ALZHEIMER’S PRONE MICE 45
Pharmacological Modulation of Long Cardiac QT Interval in Ex Vivo and in Vitro Experimental Models 45
Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients 44
Effects of nifedipine controlled release on blood pressure and heart rate of SHR hypertensive rats. Comparison with standard formulation of nifedipine and with amlodipine 44
The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1 43
Role of AT2 receptors in the cardiovascular events following microinjection of angiotensin II into the superior colliculus of anaesthetised rats 43
Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture 43
Involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty rats with metabolic syndrome 43
Cardiovascular events following microinjection of angiotensin, endothelin, and L-NAME to the superior colliculus of anestetized rats 43
Interplay between Intravitreal RvD1 and Local Endogenous Sirtuin-1 in the Protection from Endotoxin-Induced Uveitis in Rats. 43
Characterizing the anti-inflammatory and tissue protective actions of a novel annexin A1 peptide 43
Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action 42
Synthesis and antihypertensive action of new Imidazo[1,2-a]pyridine derivatives, non peptidic Angiotensin II receptor antagonists 41
Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions 41
Endothelin-1 receptor antagonists reduce cardiac electrical instability induced by high glucose in rats 41
Intraperitoneal administration of oxygen/ozone to rats reduces the pancreatic damage induced by streptozotocin 41
Lipocortin 1 inhibits myocardial infarct by reducing local neutrophil infiltration 41
MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct 40
Intraocular pressure and ß-blockers 40
Melanocortin receptor agonists MCR1-5 protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell culture 40
High glucose induces ventricular instability and increases vasomotor tone in rats 39
Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree 39
Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine 39
Endothelin-1 in the superior colliculus of rats induces depressor responses due to peripheral hemodynamic changes 39
Farmaci del sistema cardiovascolare, del sangue e del rene. Farmaci per il trattamento delle alterazioni del ricambio idroelettrolitico. 39
Selective and non-selective ET antagonists reveal an ETB receptor nediated ET-1-induced behavioural effects in conscious rats 39
Use of SPP100 for the treatment of MI 39
Inhibition of aldose-reductase-2 by a benzofuroxane derivative bf-5m increases the expression of kcne1, kcnq1 in high glucose cultured H9c2 cardiac cells and sudden cardiac death 39
MC-3 receptor and inflammatory mechanisms activated in acute myocardial infarct 37
Neuroprotection: the next step in glaucoma therapy 36
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1 35
The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage 35
Farmaci del sistema cardiovascolare, del sangue e del rene. Diuretici 35
Effects of high glucose on QT interval in isolated rat heart. 35
Endothelin-1 in periaqueductal gray area of mice induces antinociceptive effects via both ETA and ETB receptors 35
Involvement of the ubiquitin-proteasome system in the formation of experimental postsurgical peritoneal adhesions 35
Pathophysiological changes of gram-negative bacterial infection can be reproduced by a synthetic peptide mimicking loop L7 sequence of Haemophilus influenzae porin 34
Protection from Endotoxic Uveitis by Intravitreal Resolvin D1: Involvement of Lymphocytes, miRNAs, Ubiquitin-Proteasome, and M1/M2 Macrophages 33
Injection of Endothelin-1 induces depressor responses into the raphe obscurus of rats through predominant endothelin ETA receptors 33
Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. 32
Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients 32
Totale 4.964
Categoria #
all - tutte 18.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 20 13
2019/2020710 149 124 20 21 120 11 121 11 63 29 34 7
2020/2021994 81 1 116 70 174 7 125 108 10 152 101 49
2021/2022806 77 0 8 21 248 6 18 18 31 111 61 207
2022/20231.692 136 53 19 186 200 157 0 104 771 5 29 32
2023/2024368 61 14 13 48 184 15 0 27 0 6 0 0
Totale 5.405